Skip to main content

Table 2 Associations between SHR3 and clinical outcomes

From: Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study

    

Univariable analysis

Multivariable analysis*

 

SHR1-2

SHR3

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

Total population

 MACEs

867 [24.00%]

680 [37.69%]

 < 0.001

1.694 (1.532–1.873)

 < 0.001

1.416 (1.265–1.584)

 < 0.001

 All-cause death

506 [14.00%]

283 [15.69%]

 < 0.001

1.936 (1.647–2.276)

 < 0.001

1.507 (1.253–1.911)

 < 0.001

DM

 MACEs

256 [27.74%]

176 [42.62%]

 < 0.001

1.666 (1.375–2.019)

 < 0.001

1.408 (1.131–1.754)

0.002

 All-cause death

84 [9.10%]

71 [17.19%]

 < 0.001

1.968 (1.435–2.700)

 < 0.001

1.584 (1.088–2.307)

0.016

Non-DM

 MACEs

611 [22.71%]

504 [36.23%]

 < 0.001

1.719 (1.528–1.934)

 < 0.001

1.407 (1.233–1.606)

 < 0.001

 All-cause death

222 [8.25%]

212 [15.24%]

 < 0.001

1.932 (1.601–2.333)

 < 0.001

1.486 (1.201–1.838)

 < 0.001

  1. CI confidence interval, DM diabetes mellitus, HR hazard ration, Non-DM, non-diabetes mellitus, SHR stress hyperglycemia ratio
  2. *Adjusted for age, SBP, HR, Killip classification, diabetes, hypertension, angina, weight, anterior STE or LBBB, time to treatment > 4 h (TIMI risk score)